Seladelpar lysine dihydrate  MBX-8052

一、產品概述

Seladelpar lysine dihydrate是由Cymabay Therapeutics Inc研發的一種小分子藥物，是一種PPARδ激動劑。該藥物于2024年08月14日獲FDA批準，用于治療硬化性膽管炎。

二、主要產品

Description	Structural Formula	CAS No.	Category
Seladelpar lysine dihydrate		928821-40-3	API
ethyl   2-(4-mercapto-2-methylphenoxy)acetate		343322-82-7	intermediates
(R)-2-((4-(trifluoromethyl)phenoxy)methyl)oxirane		256372-58-4	intermediates

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.